Sophie Gautier

3.2k total citations
128 papers, 1.9k citations indexed

About

Sophie Gautier is a scholar working on Epidemiology, Toxicology and Geriatrics and Gerontology. According to data from OpenAlex, Sophie Gautier has authored 128 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Epidemiology, 23 papers in Toxicology and 20 papers in Geriatrics and Gerontology. Recurrent topics in Sophie Gautier's work include Pharmacovigilance and Adverse Drug Reactions (23 papers), Pharmaceutical Practices and Patient Outcomes (20 papers) and Acute Ischemic Stroke Management (19 papers). Sophie Gautier is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (23 papers), Pharmaceutical Practices and Patient Outcomes (20 papers) and Acute Ischemic Stroke Management (19 papers). Sophie Gautier collaborates with scholars based in France, United States and Italy. Sophie Gautier's co-authors include Régis Bordet, Thavarak Ouk, Olivier Pétrault, Marine Auffret, Maud Laprais, Didier Leys, Johana Béné, M. Bastide, Jacques Caron and Bart Staels and has published in prestigious journals such as PLoS ONE, Neurology and Stroke.

In The Last Decade

Sophie Gautier

109 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sophie Gautier France 24 491 407 327 309 235 128 1.9k
Jie Li China 29 735 1.5× 443 1.1× 206 0.6× 460 1.5× 151 0.6× 169 2.6k
Panayiotis Mitsias United States 29 828 1.7× 323 0.8× 217 0.7× 908 2.9× 131 0.6× 100 2.7k
И. И. Дедов Russia 34 551 1.1× 818 2.0× 294 0.9× 133 0.4× 231 1.0× 451 4.2k
Giulia Bivona Italy 32 513 1.0× 363 0.9× 200 0.6× 285 0.9× 605 2.6× 78 2.4k
Bruna Lo Sasso Italy 30 530 1.1× 390 1.0× 162 0.5× 248 0.8× 456 1.9× 101 2.3k
Markus Zorn Germany 26 547 1.1× 434 1.1× 379 1.2× 344 1.1× 85 0.4× 73 2.4k
Luisa Agnello Italy 31 548 1.1× 367 0.9× 162 0.5× 299 1.0× 550 2.3× 107 2.4k
Neil E. Anderson New Zealand 28 555 1.1× 418 1.0× 163 0.5× 1.1k 3.6× 100 0.4× 90 2.5k
Nicolas Weiss France 25 855 1.7× 407 1.0× 369 1.1× 688 2.2× 72 0.3× 128 2.7k
Francesco Ursini Italy 26 282 0.6× 342 0.8× 106 0.3× 200 0.6× 177 0.8× 134 2.4k

Countries citing papers authored by Sophie Gautier

Since Specialization
Citations

This map shows the geographic impact of Sophie Gautier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sophie Gautier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sophie Gautier more than expected).

Fields of papers citing papers by Sophie Gautier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sophie Gautier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sophie Gautier. The network helps show where Sophie Gautier may publish in the future.

Co-authorship network of co-authors of Sophie Gautier

This figure shows the co-authorship network connecting the top 25 collaborators of Sophie Gautier. A scholar is included among the top collaborators of Sophie Gautier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sophie Gautier. Sophie Gautier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Benaboud, Sihem, Laurent Chouchana, Sophie Gautier, et al.. (2025). WS02.06Elexacaftor/tezacaftor/ivacaftor pharmacokinetics and occurrence of behavioural disorders in children aged 2 to 5 years old. Journal of Cystic Fibrosis. 24. S5–S5.
3.
4.
Gautier, Sophie, Bénédicte Coulm, Laurent Chouchana, et al.. (2025). Pregnancy and neonatal outcome following in utero exposure to CFTR modulators: A multicentre prospective case series. Journal of Cystic Fibrosis. 24(6). 1051–1057.
5.
6.
Carton, Louise, Nathalie Chérot‐Kornobis, Sylvie Deheul, et al.. (2023). An overview of the use of psychoactive substances among students at the University of Lille during the COVID-19 health crisis: Results of the PETRA study. Dialogues in Clinical Neuroscience. 25(1). 101–111. 6 indexed citations
7.
Valnet‐Rabier, Marie‐Blanche, Sophie Gautier, Joëlle Micallef, et al.. (2023). Pharmacovigilance signals from active surveillance of mRNA platform vaccines (tozinameran and elasomeran). Therapies. 78(5). 499–507. 7 indexed citations
8.
9.
Laroche, Marie‐Laure, Sophie Gautier, Élisabeth Polard, et al.. (2022). Incidence and preventability of hospital admissions for adverse drug reactions in France: A prospective observational study (IATROSTAT). British Journal of Clinical Pharmacology. 89(1). 390–400. 15 indexed citations
10.
Lemaître, Madleen, et al.. (2021). Defining Potentially Inappropriate Prescriptions for Hypoglycaemic Agents to Improve Computerised Decision Support: A Study Protocol. Healthcare. 9(11). 1539–1539. 4 indexed citations
11.
Béné, Johana, Sophie Gautier, Aurélie Grandvuillemin, et al.. (2020). Moderate-to-severe eosinophilia induced by treatment with immune checkpoint inhibitors: 37 cases from a national reference center for hypereosinophilic syndromes and the French pharmacovigilance database. OncoImmunology. 9(1). 1722022–1722022. 37 indexed citations
12.
13.
Beuscart, Jean‐Baptiste, Sophie Gautier, Jean‐Marc Lefebvre, et al.. (2019). Polypharmacy in older patients: identifying the need for support by a community pharmacist. BMC Geriatrics. 19(1). 277–277. 26 indexed citations
14.
Béné, Johana, O. Carpentier, Marie‐Laure Laroche, et al.. (2018). Nicorandil and cutaneous ulcerations, their misdiagnosis and consequences: Illustration by five cases reports and a review of the French pharmacovigilance database. Therapies. 73(5). 409–417. 1 indexed citations
15.
Pinçon, Claire, Bénedicte Bruno, Johana Béné, et al.. (2018). Acute kidney injury after high dose etoposide phosphate: A retrospective study in children receiving an allogeneic hematopoetic stem cell transplantation. Pediatric Blood & Cancer. 65(7). e27038–e27038. 6 indexed citations
16.
17.
Portolan, Ghyslaine, Sophie Gautier, Laurence Vanlemmens, et al.. (2018). Pregnancy outcomes in women exposed to cancer chemotherapy. Pharmacoepidemiology and Drug Safety. 27(12). 1302–1308. 9 indexed citations
18.
Ouk, Thavarak, Camille Potey, Ilaria Maestrini, et al.. (2018). Neutrophils in tPA-induced hemorrhagic transformations: Main culprit, accomplice or innocent bystander?. Pharmacology & Therapeutics. 194. 73–83. 16 indexed citations
19.
Caparros, François, Nelly Dequatre‐Ponchelle, Solène Moulin, et al.. (2016). Orolingual Angioedema During or After Thrombolysis for Cerebral Ischemia. Stroke. 47(7). 1825–1830. 53 indexed citations
20.
Gautier, Sophie, Régis Bordet, David Launay, et al.. (2015). Interactions pharmacovigilance – service de médecine interne : une aide précieuse au diagnostic. La Revue de Médecine Interne. 36(8). 516–521. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jie Li Breakdown of academic impact, for papers by Panayiotis Mitsias Breakdown of academic impact, for papers by И. И. Дедов Breakdown of academic impact, for papers by Giulia Bivona Breakdown of academic impact, for papers by Bruna Lo Sasso Breakdown of academic impact, for papers by Markus Zorn Breakdown of academic impact, for papers by Luisa Agnello Breakdown of academic impact, for papers by Neil E. Anderson Breakdown of academic impact, for papers by Nicolas Weiss Breakdown of academic impact, for papers by Francesco Ursini
Rankless by CCL
2026